Paper · 56402

SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo.

Wilson DB and 2 others. J Immunol, 1976. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo. Papers, record 56402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/56402

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo.; PubMed
Journal: J Immunol; PubMed
Year: 1976; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/56402/; PubMed
The journal: https://conductscience.org/library/journal-index/2985117R; PubMed
Citations, by iCite: 27; iCite
Relative citation ratio, by iCite: 0.64; iCite
Revised in PubMed: 2009-10-27; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Wilson DB	D B
2	Marshak A	A
3	Howard JC	J C

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Immunity, Cellular	Major topic
Lymphocytes	Major topic
Animals
Epitopes
Graft vs Host Reaction
Lymphocyte Activation
Lymphocyte Culture Test, Mixed
Rats
Rats, Inbred Strains
Thoracic Duct
Time Factors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMID	Title	Journal	Year	In Papers	Source
6,973,003	Induced tolerance in F1 rats to anti-major histocompatibility complex receptors on parental T cells. Implications for self tolerance.	J Exp Med	1981	https://conductscience.org/library/papers/6973003	PubMed
6,222,131	Induction of cytotoxic T cell precursors in vivo. Role of T helper cells.	J Exp Med	1983	https://conductscience.org/library/papers/6222131	PubMed
6,216,134	Spontaneous diabetes in BB rats: evidence for a T cell dependent immune response defect.	Diabetologia	1982	https://conductscience.org/library/papers/6216134	PubMed
3,875,095	In vivo separation of two classes of T cells as determined by negative selection after the injection of UV-treated allogeneic lymphoid cells.	Proc Natl Acad Sci U S A	1985	https://conductscience.org/library/papers/3875095	PubMed
3,511,173	Immunogenicity and crossreactivity of specificity-associated markers on alloreactive T cells. Confirmation based on the model of tolerance abolition by adoptive transfer.	J Exp Med	1986	https://conductscience.org/library/papers/3511173	PubMed
2,531,192	Capacity of unprimed CD4+ and CD8+ T cells expressing V beta 11 receptors to respond to I-E alloantigens in vivo.	J Exp Med	1989	https://conductscience.org/library/papers/2531192	PubMed
2,117,641	Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.	J Exp Med	1990	https://conductscience.org/library/papers/2117641	PubMed
2,007,855	Generation of T cells with lytic specificity for atypical antigens. III. Priming F1 animals with antigen-bearing cells also having reactivity for host alloantigens allows for potent lytic T cell responses.	J Exp Med	1991	https://conductscience.org/library/papers/2007855	PubMed
1,371,720	Allogeneic tumor-specific cytotoxic T lymphocytes.	Cancer Immunol Immunother	1992	https://conductscience.org/library/papers/1371720	PubMed
301,550	The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.	J Exp Med	1977	https://conductscience.org/library/papers/301550	PubMed

1 to 10 of 13

See all 13 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/56402

GET https://conductscience.org/api/papers/v1/56402/authors

API reference For AI assistants